clinical report published in Pediatrics provides information to help healthcare providers understand the role of a written, personalized allergy and anaphylaxis emergency plan to enhance the care of children at risk of allergic reactions, including anaphylaxis.

The report offers a comprehensive written plan, with advice on individualizing instructions to suit specific patient circumstances. From the article:

National and international guidelines support the use of a written allergy and anaphylaxis emergency plan to enhance the care of children at risk of anaphylaxis. Although several plans are currently available, they differ in content and treatment recommendations, potentially leading to confusion. Thus, a universal plan may be beneficial to patients, families, health care professionals, and schools.

An allergy and anaphylaxis emergency plan, developed by the health care provider, would be beneficial for patients who are at risk of anaphylaxis and those who have been prescribed an epinephrine autoinjector.

The written plan may serve as a guide for patients, family and nonfamily caregivers, and school personnel in the management of allergic reactions.

Epinephrine is the medication of choice for the initial treatment of anaphylaxis, and early administration is associated with optimal outcomes. In the event of a definite exposure to an allergen that has previously caused a severe reaction, or if anaphylaxis develops, immediate use of epinephrine is warranted. If exposure to an allergen triggers only a mild symptom, observation only or initiating treatment with an antihistamine may be appropriate.

This allergy and anaphylaxis emergency plan allows healthcare providers the opportunity to individualize the treatment plan according to the child’s history, family input, and local regulations. Options and considerations for completing the plan are reviewed in this clinical report.